Cargando…
Evolving Paradigms in the Management and Outcomes of Sarcomatoid Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors
Renal cell carcinoma (RCC) is a common cancer that affects a significant number of patients every year around the world. The presence of sarcomatoid features in these tumors is considered a poor prognostic feature. Patients with RCC with sarcomatoid features had significantly worse outcomes when tre...
Autores principales: | Aly, Ragia, Aujla, Amandeep S., Gupta, Sachin, Gupta, Ruby, Gupta, Sorab, Kalathil, Sheila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575279/ https://www.ncbi.nlm.nih.gov/pubmed/33117461 http://dx.doi.org/10.14740/wjon1325 |
Ejemplares similares
-
Case Report: Heparin-induced thrombocytopenia in a patient with COVID-19
por: Aly, Ragia, et al.
Publicado: (2021) -
The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Extrapulmonary Small Cell Carcinoma
por: Aly, Ragia, et al.
Publicado: (2020) -
Immunotherapy: incorporation in the evolving paradigm of renal cancer management and future prospects
por: Liu, Kenneth G., et al.
Publicado: (2016) -
Primary Gastric Adenosquamous Carcinoma: A Case Report
por: Aly, Ragia, et al.
Publicado: (2020) -
The use of direct acting oral anticoagulants in patients with COVID-19 infection
por: Aly, Ragia, et al.
Publicado: (2021)